DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

Celgene (NASDAQ: CELG)

122.36 -1.76 (-1.42%)

REAL-TIME: Last trade at

Extended Hours: $122.89 $0.53 (0.43%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CELG $122.36 -1.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $123.01
Previous Close $124.12
Daily Range $122.04 - $124.57
52-Week Range $66.85 - $124.60
Market Cap $97.7B
P/E Ratio 64.98
Dividend (Yield) $0.00 (0.0%)
Volume 3,475,792
Average Daily Volume 5,966,202
Current FY EPS $3.26





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

5 Cant-Miss Reasons Why Celgene Corporation Could Soar

Celgene Corporation has issued long-term guidance that suggests significant sales and profit growth through 2020.

Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog

Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog

Pfizer Beats on Q4 Earnings, Guides Below Expectations - Analyst Blog

Do You Believe Me Now?

Celgene: Could You Be More Like Gilead, Please?

TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog

5 Big Biotech Earnings Releases To Watch This Week

IYH, AMGN, ABBV, CELG: Large Inflows Detected at ETF

Zillow Is In Limbo - Cramer's Lightning Round (1/23/15)

'Mad Money' Lightning Round: Constellation Brands the New King in Town

See More CELG News...

CELG's Top Competitors

CELG $122.36 (-1.42%)
Current stock: CELG
GILD $105.03 (-1.94%)
Current stock: GILD
BIIB $358.23 (-1.16%)
Current stock: BIIB
AMGN $158.42 (-0.82%)
Current stock: AMGN